Dorex Pharmaceuticals (India) Private Limited

Dorex Pharmaceuticals (India) Private Limited - pharma in Gurgaon, Haryana, India. FY 2026 financials & compliance.
CIN U24231HR1983PTC015949 Incorporated 20 June 1983 ROC Delhi HQ Gurgaon, Haryana, India
Active Private Limited Company pharma
Revenue · FY 2024
₹50.97 Lakh
▲ 79% YoY
Net profit · FY 2024
₹29.65 Lakh
Net margin 58.2%
EBITDA · FY 2024
₹47.12 Lakh
EBITDA margin 92.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹14.32 Lakh
Issued & subscribed
Open charges
₹1.69 Lakh
Secured borrowings
Company age
43 yrs
Est. 1983
Directors on board
2
As per MCA filings

About Dorex Pharmaceuticals (India) Private Limited

Data last updated:

Dorex Pharmaceuticals (India) Private Limited is a private limited company based in Gurgaon, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 June 1983 and has been in existence for over 43 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231HR1983PTC015949. Its GSTIN is 06AABCD0219L2ZX (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹14.32 Lakh. It is led by directors Gaurav Verma and Sandeep Verma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 230 Udyog Vihar – IV, Gurgaon, Haryana, India – 122001.

As per the financials filed for FY 2024, the company reported a revenue of ₹50.97 Lakh, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹29.65 Lakh (net margin 58.2%) and EBITDA of ₹47.12 Lakh (EBITDA margin 92.5%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 12% over five years.

As per MCA filings, the company has open charges of ₹1.69 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231HR1983PTC015949
Registration Number 015949
Incorporation Date 20 June 1983
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Dorex Pharmaceuticals (India) Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    230 Udyog Vihar – IV, Gurgaon, Haryana, India – 122001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dorex Pharmaceuticals (India) Private Limited, buy the company report.

Comprehensive company report
Dorex Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Dorex Pharmaceuticals (India) Private Limited

FY 2025 filings available

Dorex Pharmaceuticals (India) Private Limited reported revenue of ₹50.97 Lakh (up 79% YoY) for FY 2024.

Revenue · FY 2024
₹50.97 Lakh ▲ 79%
Net profit · FY 2024
₹29.65 Lakh margin 58.2%
EBITDA · FY 2024
₹47.12 Lakh margin 92.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 79%
3 years · compounded
▲ 34%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 93%
3 years · compounded
▲ 54%
5 years · compounded
▲ 13%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 79% growth in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹47.12 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹29.65 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin92.5%
Net Profit Margin58.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dorex Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of Dorex Pharmaceuticals (India) Private Limited

Dorex Pharmaceuticals (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gaurav VermaDirector19 Apr 200422 Years 7 MonthsCurrent
Sandeep VermaDirector28 Aug 200620 Years 2 MonthsCurrent

Peer comparison

Dorex Pharmaceuticals (India) Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Pepcura Pharmaceuticals Private Limited₹51.12 Lakh (FY 2025)4.0%Raipur, Chhattisgarh, India
Shree Pramukh Labs Private Limited₹51.07 Lakh (FY 2025)-9.0%Surendranagar, Gujarat, India
Naomi Laboratories Private Limited₹51.06 Lakh (FY 2025)31.0%Cuttack, Odisha, India
SBM Pharmaceuticals Private Limited₹51.04 Lakh (FY 2021)-15.0%Jaipur, Rajasthan, India
Spurt Pharmaceuticals Private Limited₹50.98 Lakh (FY 2024)-19.0%New Delhi, Delhi, India
Dorex Pharmaceuticals (India) Private Limitedthis company₹50.97 Lakh (FY 2024)₹29.65 Lakh58.2%79.0%Gurgaon, Haryana, India
Zenizen Pharmaceuticals Private Limited₹50.83 Lakh (FY 2024)12.0%Jamshedpur, Jharkhand, India
Markecho Pharmaceuticals Private Limited₹50.83 Lakh (FY 2024)17.0%Andheri, Mumbai, Maharashtra, India
Gallium Pharmaceuticals Private Limited₹50.81 Lakh (FY 2025)8.0%Nagpur, Maharashtra, India
Blismed Pharmaceuticals Private Limited₹50.79 Lakh (FY 2025)-4.0%Baddi, Himachal Pradesh, India
Lucidus Pharmaceuticals Private Limited₹50.78 Lakh (FY 2025)50.0%Cuttack Sadar, Odisha, India

To see the full peer comparison of Dorex Pharmaceuticals (India) Private Limited, buy the company report.

Auditor

Dorex Pharmaceuticals (India) Private Limited is audited by A P K A & ASSOCIATES for the financial year 2018.

Auditor firmFinancial yearFirm registration number
A P K A & ASSOCIATESFY 2018029734N

Shareholding

The shareholding of Dorex Pharmaceuticals (India) Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dorex Pharmaceuticals (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.69 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Jan 198490333954Bank of India₹1.69 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dorex Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Dorex Pharmaceuticals (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AABCD0219L2ZXHaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Dorex Pharmaceuticals (India) Private Limited, buy the company report.

Recent activity

Dorex Pharmaceuticals (India) Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Sanjay Verma ceased to be Director on 30 Sep 2024.

AGM
Dorex Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dorex Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Sanjay Verma ceased to be Director.
Appointed
Sandeep Verma was appointed as Director.
Appointed
Gaurav Verma was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 1.69 Lakh with Charge ID 90333954 was registered on 12 Jan 1984.
Incorporation
20 Jun 1983
Dorex Pharmaceuticals (India) Private Limited was registered on 20 Jun 1983 with Roc Delhi & aged 43 years 5 months as per MCA records.

Frequently asked questions

Dorex Pharmaceuticals (India) is an active private limited company based in Gurgaon, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 June 1983 (43+ years old) and is registered under CIN U24231HR1983PTC015949.

Dorex Pharmaceuticals (India) has 2 current directors:

The latest financial statements of Dorex Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dorex Pharmaceuticals (India) is 06AABCD0219L2ZX, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Dorex Pharmaceuticals (India) is U24231HR1983PTC015949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dorex Pharmaceuticals (India) was incorporated on 20 June 1983, making it 43+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Dorex Pharmaceuticals (India) by revenue are Pepcura Pharmaceuticals Private Limited, Shree Pramukh Labs Private Limited, Naomi Laboratories Private Limited, SBM Pharmaceuticals Private Limited, Spurt Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Sanjay Verma ceased to be Director on 30 Sep 2024. Sandeep Verma was appointed as Director on 28 Aug 2006. Gaurav Verma was appointed as Director on 19 Apr 2004.

The registered office of Dorex Pharmaceuticals (India) is at 230 Udyog Vihar – IV, Gurgaon, Haryana, India – 122001.

Dorex Pharmaceuticals (India) operates in the pharma industry, in the drug formulation and development segment.

Dorex Pharmaceuticals (India) has open charges of ₹1.69 Lakh and no satisfied charges on record as per latest MCA filings.